BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 2544697)

  • 1. Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.
    Weber DA; Makler PT; Watson EE; Coffey JL; Thomas SR; London J
    J Nucl Med; 1989 Jun; 30(6):1117-22. PubMed ID: 2544697
    [No Abstract]   [Full Text] [Related]  

  • 2. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bone scan as a tumour marker in prostatic carcinoma.
    Chisholm GD; Stone AR; Beynon LL; Merrick MV
    Eur Urol; 1982; 8(5):257-60. PubMed ID: 6288389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of Tc-99m phosphorus compounds in medullary carcinoma of the thyroid: report of two cases.
    Shigeno C; Fukunaga M; Yamamoto I; Dokoh S; Morita R; Hino M; Torizuka K
    Clin Nucl Med; 1982 Jun; 7(6):297-8. PubMed ID: 6282522
    [No Abstract]   [Full Text] [Related]  

  • 6. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
    Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
    Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New vistas on bone scintigraphy.
    Nucl Med Commun; 1984 Jun; 5(6):359-60. PubMed ID: 6241663
    [No Abstract]   [Full Text] [Related]  

  • 8. Extra-skeletal uptake of bone agents.
    Morton KA
    J Nucl Med Technol; 1999 Mar; 27(1):51-3. PubMed ID: 10322578
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of parathyroid hormone on technetium-99m pyrophosphate distribution in rats.
    Fogelman I; Bessent RG
    Eur J Nucl Med; 1981; 6(5):235. PubMed ID: 6265217
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
    Wang TS; Fawwaz RA; Johnson LJ; Mojdehi GE; Johnson PM
    J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of renal failure and metabolic diseases upon bone scanning in children.
    Schümichen C
    Ann Radiol (Paris); 1983; 26(6):498-504. PubMed ID: 6316830
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical studies on the detection of bone metastasis in lung cancer by bone scintigraphy].
    Nakano S; Hasegawa Y; Kajita A; Nakamura S; Horai T; Ikegami H; Matuda M; Okamoto N; Nabeshima H; Doi O; Komatubara Y; Ishigami S
    Kaku Igaku; 1983 Feb; 20(1):37-43. PubMed ID: 6308314
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of bone scintigraphy in differential diagnosis of benign bone tumors].
    Okuyama T; Suzuki H; Nakamoto K; Suzuki S
    Kaku Igaku; 1982 Dec; 19(10):1519-30. PubMed ID: 6302357
    [No Abstract]   [Full Text] [Related]  

  • 14. Reaction of 99mTc-diphosphonate with N-donor ligands.
    Johannsen B
    Int J Appl Radiat Isot; 1982 Jun; 33(6):429-32. PubMed ID: 6286510
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimizing the performance and interpretation of bone scans.
    Muroff LR
    Clin Nucl Med; 1981 Oct; 6(10S):P68-76. PubMed ID: 6271444
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased renal parenchymal accumulation of Tc-99m HDP in kidney contusion.
    Salimi Z; Vas W; Tang-Barton P; Suresh P; Carlin B
    Clin Nucl Med; 1984 Oct; 9(10):574-6. PubMed ID: 6488654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
    Armas R; Neumann R; Goldsmith SJ
    J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios.
    Buell U; Kirsch CM; Kleinhans E; Jäger B
    J Nucl Med; 1983 Dec; 24(12):1201-2. PubMed ID: 6227711
    [No Abstract]   [Full Text] [Related]  

  • 20. What do we want from a bone-scanning agent?
    Fogelman I; Bessent RG
    J Nucl Med; 1980 Mar; 21(3):296. PubMed ID: 6445001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.